iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
1.170
+0.032 (2.82%)
At close: May 12, 2025, 4:00 PM
1.147
-0.023 (-2.01%)
After-hours: May 12, 2025, 7:42 PM EDT
iSpecimen Employees
iSpecimen had 24 employees as of December 31, 2024. The number of employees decreased by 29 or -54.72% compared to the previous year.
Employees
24
Change (1Y)
-29
Growth (1Y)
-54.72%
Revenue / Employee
$387,130
Profits / Employee
-$520,742
Market Cap
2.92M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24 | -29 | -54.72% |
| Dec 31, 2023 | 53 | -22 | -29.33% |
| Dec 31, 2022 | 75 | 16 | 27.12% |
| Dec 31, 2021 | 59 | 18 | 43.90% |
| Dec 31, 2020 | 41 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ISPC News
- 4 months ago - iSpecimen Secures Suppliers for COVID-style hMPV Outbreak - Newsfile Corp
- 5 months ago - iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens - Newsfile Corp
- 5 months ago - iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers - Newsfile Corp
- 5 months ago - iSpecimen Appoints Robert Lim as CEO and Director - Newsfile Corp
- 6 months ago - iSpecimen Named Top Competitor in $4.4 Billion USD Market - Newsfile Corp
- 6 months ago - iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually - GlobeNewsWire
- 6 months ago - iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 6 months ago - iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire